Loading…

Stryker announced it has completed the acquisition of Cerus Endovascular Ltd., a medical device company focused on neurointerventional devices for treating intracranial aneurysms.
“The acquisition of Cerus Endovascular is highly complementary to Stryker’s neurovascular business, and strengthens our hemorrhagic portfolio globally.”evtoday.com
Summarized from public sources; check the original articles before acting on it.